Resveratrol inhibits nonalcoholic fatty liver disease in rats

BMC Gastroenterology

Volumn 8, Issue , 2008, Pages

  Bujanda, Luis ^a   Hijona, Elizabeth ^a   Larzabal, Mikel ^b   Beraza, Marta ^a   Aldazabal, Pablo ^b   García Urkia, Nerea ^b   Sarasqueta, Cristina ^b   Cosme, Angel ^a   Irastorza, Belen ^b   González, Alberto ^b   Arenas Jr , Juan I ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b HOSPITAL DONOSTIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; CYTOKINE; GLUCOSE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NITRIC OXIDE SYNTHASE; RESVERATROL; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; ANTIOXIDANT; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BACTERIAL TRANSLOCATION; CARBOHYDRATE DIET; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET RESTRICTION; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; FATTY LIVER; GLUCOSE BLOOD LEVEL; LIPID PEROXIDATION; LIPID STORAGE; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; RISK REDUCTION; WISTAR RAT; ANIMAL; DISEASE MODEL; DRUG EFFECT; HOSPITALIZATION; METABOLISM; RANDOMIZATION;

ANIMALS; ANTIOXIDANTS; CATALASE; DISEASE MODELS, ANIMAL; FATTY LIVER; GLUCOSE; GLUTATHIONE PEROXIDASE; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; RANDOM ALLOCATION; RATS; RATS, WISTAR; SEVERITY OF ILLNESS INDEX; STILBENES; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 52749094256     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-8-40     Document Type: Article

References (37)

1. Sheth SG Gordon FD Chopra S Nonalcoholic steatohepatitis Ann Intern Med 1997, 126(2): 137-45 9005748
2. Gholam PM Flancbaum L Machan JT Charney DA Kotle DP Nonalcoholic fatty liver disease in severely obese subjects Am J Gastroenterol 2007, 102(2):399-408 10.1111/j.1572-0241.2006.01041.x 17311652
3. Arun J Clements RH Lazenby AJ Leeth RR Abrams GA The prevalence of nonalcoholic steatohepatitis is greater in morbidly obese men compared to women Obes Surg 2006, 16(10):1351=1358 10.1381/096089206778663715 17059746
4. Shapiro H Halpern Z Bruck R Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis Gut 2007, 56(3):426-435. 10.1136/ gut.2006.094599 16931577
5. Jang M Cai L Udeani GO Slowing KV Thomas CF Beecher CW Fong HH Farnsworth NR Kingonorn AD Metha RG Moon RC Pezzuto JM Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 1997, 275(5297):218-220. 10.1126/science.275.5297.218 8985016
6. de la Lastra CA Villegas I Resveratrol as an anti-inflamatory and anti-aging agent: Mechanisms an clinical implications Mol Nutr Food Res 2005, 49(5):405-430. 10.1002/mnfr.200500022 15832402
7. Bujanda L García-Barcina M Gutiérrez-de Juan V Bidaurrazaga J Fernández de Luco M Gutiérrez-Stampa MA Larzabal M Hijona E Sarasqueta C Echenique-Elizondo M Arenas JI Effect of resveratrol on alcohol-induced mortality and liver lesions in mice BMC Gastroenterology 2006, 6:35. 1657014 17105669 10.1186/1471-230X-6-35
8. Delzenne NM Hernaux NA Taper HS A new model of acute liver steatosis induced in rats by fasting followed by refeeding a high carbohydrate-fat free diet. Biochemical and morphological analysis J Hepatol 1997, 26(4):880-885. 10.1016/S0168-8278(97)80256-5 9126803
9. Brunt EM Janney CG Di Bisceglie AM Neuschwander-Tetri BA Bacon BR Nonalcoholi steatohepatitis: A proposal for grading and staging the histological lesions Am J Gastroenterol 1999, 94(9):2467-2474. 10.1111/ j.1572-0241.1999.01377.x 10484010
10. Ohkawa H Ohishi N Yagi K Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal Biochem 1979, 95(2):351-358. 10.1016/ 0003-2697(79)90738-3 36810
11. Parekh S Anania FA Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease Gastroenterology 2007, 132(6):2191-2207. 10.1053/j.gastro.2007.03.055 17498512
12. James O Day C Non-alcoholic steatohepatitits: Another disease of affluence Lancet 1999, 353(9165):1634-1636. 10.1016/ S0140-6736(99)00163-4 10335777
13. Day CP Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease Liver International 2006, 26(9):1021-1028. 10.1111/j.1478-3231.2006.01323.x 17032401
14. Chu CJ Lu RH Wang SS Chang FY Wu SL Lu CL Chun BC Chang CY Wu MY Lee SD Risk factors associated with non-alcoholic fatty liver disease in Chinese patients and the role of tumor necrosis factor-alpha Hepatogastroenterology 2007 54 79 2099 2102 18251167
15. Jarrar MH Baranova A Collantes R Ranard B Stepanova M Bennett C Fang Y Elariny H Goodman Z Chandhoke V Younossi ZM Adipokines and cytokines in non-alcoholic fatty liver disease Aliment Pharmacol Ther 2008, 27(5):412-421. 18081738
16. Manco M Marcellini M Giannone G Nobili V Correlation of serum TNF-alpha levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease Am J Clin Pathol 2007, 127(6):954-960. 10.1309/ 6VJ4DWGYDU0XYJ8Q 17509993
17. Seo YS Kim JH Jo NY Choi KM Baik SH Park JJ Kim JS Byun KS Bak YT Lee CH Kim A Yeon JE PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes J Gastroenterol Hepatol 2008, 23(1):102-109. 18171348
18. Lieber CS DeCarli LM Leo MA Mak KM Ponomarenko A Ren C Wang X Beneficial effects versus toxicity of medium-chin trialcylglycerols in rats with NASH J Hepatol 2008, 48(2):318-26. 10.1016/j.jhep.2007.09.016 18093684
19. Yalniz M Bahcecioglu IH Kuzu N Poyrazoglu OK Bulmus O Celebi S Ustundag B Ozercan IH Sahin K Preventive role of genistein in an experimental non-alcoholic steatohepatitis model J Gastroenterol Hepatol 2007, 22(11):2009-14. 10.1111/j.1440-1746.2006.04681.x 17914984
20. Barbuio R Milanski M Bertolo MB Saad MJ Vellosos LA Infliximab reverses stetatosis and improves insulin signal transduction in liver of rats fed a high-fat diet J Endocrinol 2007, 194(3):539-550. 10.1677/JOE-07-0234 17761893
21. Francés R Chiva M Sánchez E González-Navajas JM Llovet T Zapater P Soriano G Muñoz C Balanzó J Pérez-Mateo M Song X Guarner C Such J Bacterial translocation is downregulated by anti-TNF-alpha monoclonal antibody administration in rats with cirrhosis and ascites J Hepatol 2007, 46(5):797-803. 10.1016/ j.jhep.2006.11.018 17321632
22. Lieber CS Leo MA Mak KM Xu Y Cao Q Ren C Ponomarenko A DeCarli LM Model of nonalcoholic steatohepatitis Am J Clin Nutr 2004, 79(3):502-509. 14985228
23. Koteish A Diehl AM Animal models of steatosis Semin Liver Dis 2001, 21(1):89-104. 10.1055/s-2001-12932 11296700
24. Shoelson SE Herrero L Naaz A Obesity, inflammation and insulin resistance Gastroenterology 2007, 132(6):2169-2180. 10.1053/ j.gastro.2007.03.059 17498510
25. Ota T Takamura T Kurita S Matsuzawa N Kita Y Uno M Akahori H Misu H Sakurai M Zen Y Nakamura Y Kaneko S Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis Gastroenterology 2007, 132(1):282-293. 10.1053/j.gastro.2006.10.014 17241878
26. Baur JA Pearson KJ Price NL Jamieson HA Lerin C Kalra A Prabhu VV Allard JS Lopez-Lluch G Lewis K Pistell PJ Poosala S Becker KG Boss O Gwinn D Wang M Ramaswamy S Fishbein KW Spencer RG Lakatta EG Le Couteur D Shaw RJ Navas P Pueigserver P Ingram KD de Cabo R Sinclair DA Resveratrol improves health and survival of mice on a high-calorie diet Nature 2006, 444(7117):337-342. 10.1038/nature05354 17086191
27. Milne JC Lambert PD Schenk S Carney DP Smith JJ Gagne DJ Jin L Boss O Perni RB Vu CB Bemis JE Xie R Disch JS Ng PY Nunes JJ Lynch AV Yang H Galonek H Israelian K Choy W Iffland A Lavu S Medvedik O Sinclair DA Olefsky JM Jirousek MR Elliott PJ Westphal CH Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes Nature 2007, 450(7170):712-716. 10.1038/nature06261 18046409
28. Thong-Ngam D Samuhasaneeto S Kulaputana O Klaikeaw N N-acetylcysteine attenuates oxidative stress and liver pathology in rats with non-alcoholic steatohepatitis World J Gastroenterol 2007 13 38 5127 5132 17876880
29. Garcia-Ruiz C Colell A Morales A Kaplowitz N Fernandez Checa JC Role of oxidative stress generated form the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-kappa B: studies with isolated mitochondria and rat hepatocytes Mol Pharmacol 1995, 48(5):825-834. 7476912
30. Weltman MD Farrell GC Liddle C Increased hepatocytes CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation Gastroenterology 1996, 111(6):1645-1653. 10.1016/S0016-5085(96)70028-8 8942745
31. Browining JD Horton JD Molecular mediators of hepatic steatosis and liver injury J Clin Invest 2004, 114(2):147-152. 449757 15254578
32. Kono H Rusyn I Yin M Gäbele E Yamashina S Dikalova A Kadiiska MB Connor HD Mason RP Segal BH Bradford BU Holland SM Thurman RG NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease J Clin Invest 2000, 106(7):867-872. 517812 11018074 10.1172/ JCI9020
33. Leonard SS Xia C Jiang BH Stinefelt B Klandorf H Harris GK Shi X Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses Biochem Biophys Res Commun 2003, 309(4):1017-1026. 10.1016/j.bbrc.2003.08.105 13679076
34. Wu SL Yu L Meng KW Ma ZH Pan CE Resveratrol prolongs allograft survival after liver transplantation in rats World J Gastroenterol 2005, 11(30):4745-4749. 16094722
35. Deng XQ Chen LL Li NX The expression of SIRT1 in non-alcoholic fatty liver disease induced by high fat diet in rats Liver Int 2007, 27(5):708-715. 10.1111/j.1478-3231.2007.01497.x 17498258
36. Pfluger PT Herranz D Velasco-Miguel S Serrano M Tschop MH SIRT1 protects against high-fat diet-induced metabolic damage Proc Natl Acad Sci USA 2008, 105(28):9793-9798. 10.1073/pnas.0802917105 18599449
37. Shang J Chen L Xiao F Sun H Ding H Xiao H Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase Acta Pharmacol Sin 2008, 29(6):698-706. 10.1111/ j.1745-7254.2008.00807.x 18501116